Bloomberg reported on Friday that KKR & Co’s potential sale of its scientific measurement and testing company LGC Group has received interest from medical device makers Thermo Fisher Scientific Inc and Danaher Corp.
The report cited some people familiar with the matter who said that the sale of LGC could help the private equity firm get more than $2 billion, including debt.
The report added that talks are at an early stage and offers for the business are also being weighed in by CVC Capital Partners, Carlyle Group LP, Blackstone Group Inc, and EQT Partners.
Also, the report stated that LGC, previously known as, Laboratory of the Government Chemist, after factoring in its recent acquisitions leads to the generation of annual earnings before interest, taxes, depreciation, and amortization of about $150 million.
EQT Partners and a KKR spokeswoman refrained from commenting to Reuters request. Nor did Thermo Fisher and Danaher responded immediately to the request for comment, neither did Blackstone, Carlyle and CVC Capital immediately respond.